OULU, Finland--(BUSINESS WIRE)--BioSilta announces the release of the EnPresso™ Tablet Cultivation Set, a tabletised form of the patented EnBase® technology. The EnBase technology is based on providing an enzymatic-controlled glucose supply in a fed-batch type manner, which allows an extended growth period and promotes higher final cell density. This methodology regulates the growth of the microbe without oxygen limitation and facilitates more efficient protein production in recombinant Escherichia coli. In addition, EnBase has been used with various microorganisms and in bioprocess scale-up, protein production and optimization, enzyme screening, protein crystallography, plasmid production and brewery contaminant detection.